Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stacy W Gray

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
JAMA Health Forum|June 27, 2022
A Framework for Promoting Diversity, Equity, and Inclusion in Genetics and Genomics ResearchTimothy R Rebbeck, John F P Bridges, Jennifer W Mack, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 8, 2013
Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research ConsortiumJonathan S Berg, Laura M Amendola, Christine Eng, et al.
JCO Oncology Practice|April 2, 2021
Patient Knowledge and Expectations About Return of Genomic Results in a Biomarker-Driven Master Protocol Trial (SWOG S1400GEN)Joshua A Roth, Meghna S Trivedi, Stacy W Gray, et al.
Contemporary Clinical Trials|May 30, 2026
Rationale and study design for a randomized clinical trial of HOPE-genomics, a web-based intervention to improve cancer patients' understanding of genomic testing resultsIlana Solomon, Marilan Luong, Madeline Currey, et al.
Cancer|April 15, 2021
Germline mutations and age at onset of lung adenocarcinomaKaren L Reckamp, Carolyn E Behrendt, Thomas P Slavin, et al.
JCO Precision Oncology|February 9, 2022
Use of Next-Generation Sequencing Tests to Guide Cancer Treatment: Results From a Nationally Representative Survey of Oncologists in the United StatesAndrew N Freedman, Carrie N Klabunde, Kristine Wiant, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2018
Identification of Incidental Germline Mutations in Patients With Advanced Solid Tumors Who Underwent Cell-Free Circulating Tumor DNA SequencingThomas P Slavin, Kimberly C Banks, Darya Chudova, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 5, 2021
The Association between Polluted Neighborhoods and <i>TP53</i>-Mutated Non-Small Cell Lung CancerLoretta Erhunmwunsee, Sam E Wing, Jenny Shen, et al.
Journal of the American Medical Informatics Association : JAMIA|July 5, 2015
CSER and eMERGE: current and potential state of the display of genetic information in the electronic health recordBrian H Shirts, Joseph S Salama, Samuel J Aronson, et al.
American Journal of Human Genetics|May 13, 2014
Return of genomic results to research participants: the floor, the ceiling, and the choices in betweenGail P Jarvik, Laura M Amendola, Jonathan S Berg, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
JAMA Health Forum|June 27, 2022
A Framework for Promoting Diversity, Equity, and Inclusion in Genetics and Genomics ResearchTimothy R Rebbeck, John F P Bridges, Jennifer W Mack, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 8, 2013
Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research ConsortiumJonathan S Berg, Laura M Amendola, Christine Eng, et al.
JCO Oncology Practice|April 2, 2021
Patient Knowledge and Expectations About Return of Genomic Results in a Biomarker-Driven Master Protocol Trial (SWOG S1400GEN)Joshua A Roth, Meghna S Trivedi, Stacy W Gray, et al.
Contemporary Clinical Trials|May 30, 2026
Rationale and study design for a randomized clinical trial of HOPE-genomics, a web-based intervention to improve cancer patients' understanding of genomic testing resultsIlana Solomon, Marilan Luong, Madeline Currey, et al.
Cancer|April 15, 2021
Germline mutations and age at onset of lung adenocarcinomaKaren L Reckamp, Carolyn E Behrendt, Thomas P Slavin, et al.
JCO Precision Oncology|February 9, 2022
Use of Next-Generation Sequencing Tests to Guide Cancer Treatment: Results From a Nationally Representative Survey of Oncologists in the United StatesAndrew N Freedman, Carrie N Klabunde, Kristine Wiant, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2018
Identification of Incidental Germline Mutations in Patients With Advanced Solid Tumors Who Underwent Cell-Free Circulating Tumor DNA SequencingThomas P Slavin, Kimberly C Banks, Darya Chudova, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 5, 2021
The Association between Polluted Neighborhoods and <i>TP53</i>-Mutated Non-Small Cell Lung CancerLoretta Erhunmwunsee, Sam E Wing, Jenny Shen, et al.
Journal of the American Medical Informatics Association : JAMIA|July 5, 2015
CSER and eMERGE: current and potential state of the display of genetic information in the electronic health recordBrian H Shirts, Joseph S Salama, Samuel J Aronson, et al.
American Journal of Human Genetics|May 13, 2014
Return of genomic results to research participants: the floor, the ceiling, and the choices in betweenGail P Jarvik, Laura M Amendola, Jonathan S Berg, et al.
Pageof 9